Related Experiment Video
Updated: Aug 1, 2026

10:41
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
[Segawa's disease: progressive dystonia responsive to L-dopa. A case report]
1Neurologista-pesquisador da Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brasil.
Arquivos De Neuro-Psiquiatria
|December 1, 1993
Summary
Segawa's disease, a hereditary dystonia, presents with diurnal fluctuations and L-dopa responsiveness. Misdiagnosis as Strumpell's disease occurred due to family history, highlighting diagnostic challenges.
Area of Science:
- Neurology
- Genetics
- Movement Disorders
Background:
- Segawa's disease (SD) is a rare, inherited neurological disorder characterized by progressive dystonia.
- Key features include diurnal fluctuations in symptoms and significant improvement with L-dopa treatment.
- Early diagnosis is crucial for effective management.
Observation:
- A case study of a 28-year-old woman with Segawa's disease, onset at age 18, is presented.
- The patient was misdiagnosed with Strumpell's hereditary spastic paraplegia for over a decade due to a family history of a similar condition.
- Family members exhibited related neurological signs, including atypical gait and motor developmental delay.
Findings:
- The patient's symptoms, typical of Segawa's disease, were initially overlooked due to a misdiagnosis.
- Pes cavus was identified as a common physical trait among the patient, her father, and her affected cousin.
- The diagnostic delay underscores the importance of recognizing distinct clinical presentations of hereditary neurological disorders.
Implications:
- This case highlights the challenges in diagnosing Segawa's disease, especially with co-existing family history of other hereditary neurological conditions.
- Accurate diagnosis is essential for initiating timely and effective L-dopa therapy.
- Further research into genetic factors and clinical presentations can improve diagnostic accuracy for SD and related disorders.
Related Concept Videos
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

